aripiprazole has been researched along with Genetic Predisposition in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Calabrese, JR; Deyling, E; Findling, RL; Lingler, J; Lytle, S; McNamara, NK; McVoy, M; Rowles, BM; Stansbrey, RJ; Youngstrom, EA | 1 |
| Li, W; Lv, L; Wang, S; Wang, X; Yang, G; Yang, Y; Zhang, H; Zhao, J | 1 |
| Nelson, R; Pumariega, AJ; Rotenberg, L | 1 |
| Chen, CH; Chen, SF; Chen, SJ; Chen, YJ; Lin, CC; Luu, SU; Shen, YC | 1 |
1 trial(s) available for aripiprazole and Genetic Predisposition
| Article | Year |
|---|---|
A Double-Blind and Placebo-Controlled Trial of Aripiprazole in Symptomatic Youths at Genetic High Risk for Bipolar Disorder.
Topics: Adolescent; Age Factors; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Child; Child of Impaired Parents; Child, Preschool; Double-Blind Method; Female; Genetic Predisposition to Disease; Humans; Male; Risk Factors | 2017 |
3 other study(ies) available for aripiprazole and Genetic Predisposition
| Article | Year |
|---|---|
Association of microRNA137 gene polymorphisms with age at onset and positive symptoms of schizophrenia in a Han Chinese population.
Topics: Adult; Age of Onset; Aripiprazole; China; Female; Genetic Predisposition to Disease; Genotype; Humans; Male; MicroRNAs; Phenotype; Piperazines; Polymorphism, Genetic; Psychiatric Status Rating Scales; Quinolones; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2014 |
Varenicline-induced mixed mood and psychotic episode in a patient with a past history of depression.
Topics: Antipsychotic Agents; Aripiprazole; Benzazepines; Bipolar Disorder; Depressive Disorder; Female; Genetic Predisposition to Disease; Humans; Middle Aged; Piperazines; Psychoses, Substance-Induced; Psychotherapy; Quinolones; Quinoxalines; Smoking Cessation; Stress, Psychological; Varenicline | 2008 |
Effects of DRD2/ANKK1 gene variations and clinical factors on aripiprazole efficacy in schizophrenic patients.
Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Female; Follow-Up Studies; Genetic Predisposition to Disease; Hospitalization; Humans; Male; Middle Aged; Piperazines; Polymorphism, Genetic; Protein Serine-Threonine Kinases; Psychiatric Status Rating Scales; Quinolones; Receptors, Dopamine D2; Schizophrenia; Taiwan; Treatment Outcome; Young Adult | 2009 |